|
|
The plasma proteome is both the most useful and
the most difficult version of the human proteome. Clinical exploitation of
its value faces major technical, regulatory, financial and IP barriers.
|
|
New papers: A List of Candidate Cancer Biomarkers for Targeted Proteomics [Complete list as spreadsheet]
and
Quantitative MRM Assays for Major Plasma Proteins
- Other PPI papers and available fulltext
PPI slide presentation at ABRF meeting in Longbeach CA, Feb 2006 (7 MB)
- Other PPI slide presentations
|
|
|
PPI is collaborating to develop the
databases and measurement technology required to validate candidate marker
panels in large clinical samples sets.
|
|
The Canary Foundation has provided a seed grant to accelerate PPI's work on the SISCAPA biomarker validation technology
PPI has formed a collaboration with Molecular Connections (Bangalore) to advance the Plasma Protein Database |
